SpeeDx Receives CE-IVD Mark for ResistancePlus® GC Gonorrhea Test
06. Dezember 2018 03:30 ET
|
SpeeDx Pty Ltd
SYDNEY, Australia, Dec. 06, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its ResistancePlus® GC assay that detects both the sexually transmitted...
SpeeDx broaden distribution network across Europe
08. November 2018 04:00 ET
|
SpeeDx Pty Ltd
AxonLab, Diamedica, Vircell and Biomedica sign on as new distribution partners SYDNEY, Australia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- SpeeDx have announced the signing of a further four distribution...
SpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG Test
25. September 2018 08:00 ET
|
SpeeDx Pty Ltd
SYDNEY, Australia, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. today announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG (not...
UK drafts new M. genitalium guidelines: Resistance Guided Therapy to tackle antibiotic resistance
23. Juli 2018 03:00 ET
|
SpeeDx Pty Ltd
LONDON, July 23, 2018 (GLOBE NEWSWIRE) -- The British Association of Sexual Health and HIV (BASHH) draft guidelines for the sexually transmitted infection Mycoplasma genitalium (Mgen) were posted...
Clinical data demonstrates significantly increased cure rates using Resistance Guided Therapy for treating the STI Superbug M. genitalium
21. Juni 2018 03:00 ET
|
SpeeDx Pty Ltd
SYDNEY, Australia, June 21, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. today announced clinical data contained in a new study published in the June 2018 issue of Clinical Infectious Diseases1 [ link]...
SpeeDx and Serosep sign UK and Ireland distribution agreement
23. April 2018 01:00 ET
|
SpeeDx Pty Ltd
SYDNEY, Australia, April 23, 2018 (GLOBE NEWSWIRE) -- SpeeDx has announced a distribution agreement with Serosep Ltd, a leading manufacturer and distributor of laboratory diagnostic solutions. This...
SpeeDx receives FDA clearance for Mycoplasma genitalium product
19. April 2018 08:00 ET
|
SpeeDx Pty Ltd
SYDNEY, Australia, April 19, 2018 (GLOBE NEWSWIRE) -- SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United...
SpeeDx Pty. Ltd. establishes US-based operation
04. Dezember 2017 08:00 ET
|
SpeeDx Pty Ltd
SYDNEY, Australia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd, a developer of advanced multiplex molecular diagnostic solutions, announced the incorporation of a US-based subsidiary company,...